Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- CEOs and Executives of Companies Filing for Bankruptcy Make Millions also categorized in BoardNews
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- McDonald’s Board Members Sued Over ‘Lavish’ $56 Million Severance for Fired CEO Easterbrook also published in Chicago Tribune
- UBS Still Needs to Get Rid of Investment Bank - Activist Investor also written by Reuters
- Exclusive: IBM hired advisers to deal with restless investors - sources also written by Reuters
- Lululemon Has A New CEO also written by Reuters
- Ford Fires CEO Mark Fields; Former Steelcase Chief Jim Hackett To Take Over also categorized in BoardNews
- New Walgreens CEO to Get Nearly $25 Million Signing Bonus also published in Chicago Tribune
- Billionaire Investor Bill Ackman Trims Stake In Chipotle, But Is Still Betting Big On Burritos With 5% Stake also categorized in BoardNews
- CEOs Are Cutting Their Own Salaries In Response To The Coronavirus also categorized in BoardNews
Login to comment.